Vimian Group AB

  • Market Cap: Small Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: SE0015961982
SEK
29.94
1.14 (3.96%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationScore
Click here to find our call on this stock
Strong Sell
Sell
Hold
Buy
Strong Buy

MarketsMojo — Loved in India, Now Global

The power of Mojo is now in 29 countries. Explore global equities with the same cutting-edge features you love.

Comparison
Company
Score
Quality
Valuation
Financial
Technical
Saniona AB
Vimian Group AB
Probi AB
Biovica International AB
Intervacc AB
BioInvent International AB
BICO Group AB
Alligator Bioscience AB
Magle Chemoswed Holding AB
Mendus AB
Bio-Works Technologies AB
Why is Vimian Group AB ?
1
Poor Management Efficiency with a low ROCE of 7.21%
  • The company has been able to generate a Return on Capital Employed (avg) of 7.21% signifying low profitability per unit of total capital (equity and debt)
2
High Debt Company with a Debt to Equity ratio (avg) at times
  • High Debt Company with a Debt to Equity ratio (avg) at times
  • The company has been able to generate a Return on Equity (avg) of 3.39% signifying low profitability per unit of shareholders funds
3
Healthy long term growth as Net Sales has grown by an annual rate of 81.43% and Operating profit at 80.15%
  • OPERATING CASH FLOW(Y) Highest at SEK 906.37 MM
  • ROCE(HY) Highest at 3.34%
  • NET PROFIT(Q) At SEK 98.35 MM has Grown at 82.27%
4
With ROE of 5.06%, it has a fair valuation with a 2.01 Price to Book Value
  • The stock is trading at a premium compared to its peers' average historical valuations
  • Over the past year, while the stock has generated a return of -32.87%, its profits have risen by 99.1% ; the PEG ratio of the company is 0.4
5
Below par performance in long term as well as near term
  • Along with generating -32.87% returns in the last 1 year, the stock has also underperformed OMX Stockholm 30 in the last 3 years, 1 year and 3 months
stock-recommendationReal-Time Research Report
Verdict Report
How much should you hold?
  1. Overall Portfolio exposure to Vimian Group AB should be less than 10%
  2. Overall Portfolio exposure to Pharmaceuticals & Biotechnology should be less than 30%

(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)

When to exit? - We will constantly monitor the company and suggest at the appropriate time to exit from the stock

Is Vimian Group AB for you?

High Risk, Low Return

Absolute
Risk Adjusted
Volatility
Vimian Group AB
-32.87%
-0.30
44.64%
OMX Stockholm 30
8.01%
0.44
18.11%
stock-recommendationQuality
stock-summaryManagement Risk
stock-summaryGrowth
stock-summaryCapital Structure
stock-recommendation
Quality grade scale :

Below Average, Average, Good, Excellent

Quality key factors
Factor
Value
Sales Growth (5y)
81.43%
EBIT Growth (5y)
80.15%
EBIT to Interest (avg)
3.45
Debt to EBITDA (avg)
2.40
Net Debt to Equity (avg)
0.22
Sales to Capital Employed (avg)
0.41
Tax Ratio
35.21%
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
0
ROCE (avg)
7.21%
ROE (avg)
3.39%
stock-recommendationValuation
Valuation Scorecard stock-summary
stock-recommendation
Valuation grade scale :

Very Risky, Risky, Very Expensive, Expensive, Fair, Attractive, Very Attractive

Valuation Key Factors stock-summary
Factor
Value
P/E Ratio
40
Industry P/E
Price to Book Value
2.01
EV to EBIT
23.00
EV to EBITDA
15.22
EV to Capital Employed
1.77
EV to Sales
3.90
PEG Ratio
0.41
Dividend Yield
NA
ROCE (Latest)
7.70%
ROE (Latest)
5.06%
stock-recommendationTechnicals
Technical key factors
Indicator
Weekly
Monthly
MACD
Mildly Bullish
Bearish
RSI
No Signal
No Signal
Bollinger Bands
Bearish
Bearish
Moving Averages
Mildly Bearish (Daily)
KST
Mildly Bullish
Mildly Bearish
Dow Theory
No Trend
No Trend
OBV
Mildly Bearish
Mildly Bullish
stock-recommendation Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish  Turned 
Technical Movement
stock-recommendationFinancial Trend
Financial Trend Scorecard stock-summary
stock-recommendation
Financial Trend scale:

Very Negative, Negative, Flat, Positive, Very Positive, Outstanding

11What is working for the Company
OPERATING CASH FLOW(Y)

Highest at SEK 906.37 MM

ROCE(HY)

Highest at 3.34%

NET PROFIT(Q)

At SEK 98.35 MM has Grown at 82.27%

-1What is not working for the Company
RAW MATERIAL COST(Y)

Grown by 10.7% (YoY

Here's what is working for Vimian Group AB
Operating Cash Flow
Highest at SEK 906.37 MM and Grown
In each year in the last three years
MOJO Watch
The company has generated higher cash revenues from business operations

Operating Cash Flows (SEK MM)

Net Profit
At SEK 98.35 MM has Grown at 82.27%
over average net sales of the previous four periods of SEK 53.96 MM
MOJO Watch
Near term Net Profit trend is positive

Net Profit (SEK MM)

Here's what is not working for Vimian Group AB
Raw Material Cost
Grown by 10.7% (YoY)
MOJO Watch
The company's ability to pass on the cost of raw materials to customers has deteriorated; this may lead to a fall in profit margin

Raw Material Cost as a percentage of Sales